Barlev NA - Search Results

1

26S proteasome exhibits endoribonuclease activity controlled by extra-cellular stimuli.

Kulichkova VA, Tsimokha AS, Fedorova OA, Moiseeva TN, Bottril A, Lezina L, Gauze LN, Konstantinova IM, Mittenberg AG, Barlev NA. Kulichkova VA, et al. Among authors: barlev na. Cell Cycle. 2010 Feb 15;9(4):840-9. doi: 10.4161/cc.9.4.10829. Epub 2010 Mar 2. Cell Cycle. 2010. PMID: 20139718

2

Role of proteasomes in transcription and their regulation by covalent modifications.

Mittenberg AG, Moiseeva TN, Barlev NA. Mittenberg AG, et al. Among authors: barlev na. Front Biosci. 2008 May 1;13:7184-92. doi: 10.2741/3220. Front Biosci. 2008. PMID: 18508726 Review.

3

Proteomic analysis of the 20S proteasome (PSMA3)-interacting proteins reveals a functional link between the proteasome and mRNA metabolism.

Fedorova OA, Moiseeva TN, Nikiforov AA, Tsimokha AS, Livinskaya VA, Hodson M, Bottrill A, Evteeva IN, Ermolayeva JB, Kuznetzova IM, Turoverov KK, Eperon I, Barlev NA. Fedorova OA, et al. Among authors: barlev na. Biochem Biophys Res Commun. 2011 Dec 16;416(3-4):258-65. doi: 10.1016/j.bbrc.2011.10.126. Epub 2011 Nov 2. Biochem Biophys Res Commun. 2011. PMID: 22079093

4

Hot and toxic: hyperthermia and anti-mitotic drugs in cancer therapy.

Barlev NA. Barlev NA. Cell Cycle. 2013 Aug 15;12(16):2533. doi: 10.4161/cc.25841. Epub 2013 Jul 30. Cell Cycle. 2013. PMID: 23907158 Free PMC article. No abstract available.

5

DNA damage-induced ubiquitylation of proteasome controls its proteolytic activity.

Moiseeva TN, Bottrill A, Melino G, Barlev NA. Moiseeva TN, et al. Among authors: barlev na. Oncotarget. 2013 Sep;4(9):1338-48. doi: 10.18632/oncotarget.1060. Oncotarget. 2013. PMID: 23907514 Free PMC article.

6

Immunoaffinity purification of the functional 20S proteasome from human cells via transient overexpression of specific proteasome subunits.

Livinskaya VA, Barlev NA, Nikiforov AA. Livinskaya VA, et al. Among authors: barlev na. Protein Expr Purif. 2014 May;97:37-43. doi: 10.1016/j.pep.2014.02.011. Epub 2014 Feb 28. Protein Expr Purif. 2014. PMID: 24583181

7

Characterization of novel markers of senescence and their prognostic potential in cancer.

Althubiti M, Lezina L, Carrera S, Jukes-Jones R, Giblett SM, Antonov A, Barlev N, Saldanha GS, Pritchard CA, Cain K, Macip S. Althubiti M, et al. Cell Death Dis. 2014 Nov 20;5(11):e1528. doi: 10.1038/cddis.2014.489. Cell Death Dis. 2014. PMID: 25412306 Free PMC article.

8

Current genome editing tools in gene therapy: new approaches to treat cancer.

Shuvalov O, Petukhov A, Daks A, Fedorova O, Ermakov A, Melino G, Barlev NA. Shuvalov O, et al. Among authors: barlev na. Curr Gene Ther. 2015;15(5):511-29. doi: 10.2174/1566523215666150818110241. Curr Gene Ther. 2015. PMID: 26282844 Review.

9

The 26S proteasome is a multifaceted target for anti-cancer therapies.

Grigoreva TA, Tribulovich VG, Garabadzhiu AV, Melino G, Barlev NA. Grigoreva TA, et al. Among authors: barlev na. Oncotarget. 2015 Sep 22;6(28):24733-49. doi: 10.18632/oncotarget.4619. Oncotarget. 2015. PMID: 26295307 Free PMC article. Review.

10

Regulation of Endoribonuclease Activity of Alpha-Type Proteasome Subunits in Proerythroleukemia K562 Upon Hemin-Induced Differentiation.

Mittenberg AG, Moiseeva TN, Kuzyk VO, Barlev NA. Mittenberg AG, et al. Among authors: barlev na. Protein J. 2016 Feb;35(1):17-23. doi: 10.1007/s10930-015-9642-x. Protein J. 2016. PMID: 26661102

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

132 results

Search Page